Russ Cohen

Most Popular

Aptose Biosciences Surges Ahead with Q1 Earnings Aptose Biosciences Surges Ahead with Q1 Earnings

APTO stock - APTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024

Source: iQoncept / Shutterstock

Aptose Biosciences (NASDAQ:APTO) recently unveiled its performance for the initial quarter of 2024.

  • Aptose Biosciences surpassed expectations by reporting earnings per share of -73 cents, slightly better than the projected -74 cents.
  • Despite this positive development, the company did not disclose any revenue figures for the period.

InvestorPlace Earnings, fueled by TradeSmith data, promptly shares the latest on quarterly earnings reports. The automated reports present essential insights such as earnings per share, revenue details, and performance relative to analyst forecasts. This swift dissemination of data ensures our audience remains well-informed. For queries or corrections, please reach out to us at editor@investorplace.com.

Article printed from InvestorPlace Media

© 2024 InvestorPlace Media, LLC


5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

See also  DASH Benefits From Robust E-Commerce Growth: More Upside Ahead?

Latest articles

NVIDIA Made My Followers Millionaires. Now I’m Looking for the Next One.

Russ Cohen

Why Satellogic Could Be One of the Biggest Space Winners of 2026

Russ Cohen

Cerebras IPO: Here's What a $5,000 Investment Could Look Like in 5 Years

Russ Cohen